celontin

Generic: methsuximide

Labeler: parke-davis div of pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name celontin
Generic Name methsuximide
Labeler parke-davis div of pfizer inc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

methsuximide 300 mg/1

Manufacturer
Parke-Davis Div of Pfizer Inc

Identifiers & Regulatory

Product NDC 0071-0525
Product ID 0071-0525_986234db-3ad4-41d4-9fbd-340f79439708
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA010596
Listing Expiration 2026-12-31
Marketing Start 1957-02-08

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00710525
Hyphenated Format 0071-0525

Supplemental Identifiers

RxCUI
197949 207088
UPC
0300710525245
UNII
0G76K8X6C0
NUI
N0000175753 N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name celontin (source: ndc)
Generic Name methsuximide (source: ndc)
Application Number NDA010596 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (0071-0525-24)
source: ndc

Packages (1)

0071-0525-24 100 CAPSULE in 1 BOTTLE (0071-0525-24)

Ingredients (1)

methsuximide (300 mg/1)

Linked Drug Pages (1)

Celontin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "986234db-3ad4-41d4-9fbd-340f79439708", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0300710525245"], "unii": ["0G76K8X6C0"], "rxcui": ["197949", "207088"], "spl_set_id": ["64a6ee88-c6b1-4e13-8208-b6772ef65a74"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0071-0525-24)", "package_ndc": "0071-0525-24", "marketing_start_date": "19570208"}], "brand_name": "Celontin", "product_id": "0071-0525_986234db-3ad4-41d4-9fbd-340f79439708", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0071-0525", "generic_name": "methsuximide", "labeler_name": "Parke-Davis Div of Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Celontin", "active_ingredients": [{"name": "METHSUXIMIDE", "strength": "300 mg/1"}], "application_number": "NDA010596", "marketing_category": "NDA", "marketing_start_date": "19570208", "listing_expiration_date": "20261231"}